Hainan Zholly Pharmaceutical

Hainan Zholly Pharmaceutical is a Chinese pharmaceutical enterprise focused on the development and production of high-quality generic medications. Established in 1994, the company has built a robust portfolio centered on anti-infectives, cardiovascular treatments, and respiratory drugs. Its manufacturing capabilities include various dosage forms such as tablets, capsules, and granules, all produced under strict GMP standards. The company is a significant player in the Hainan pharmaceutical cluster, serving both domestic and international markets with essential medicines. Key products include widely used antibiotics like Cefixime and Azithromycin, alongside chronic disease treatments for hypertension. Zholly maintains a strong emphasis on quality control and has received numerous provincial awards for its industrial contributions.